$9.70
-0.02[-0.21%]
At close: Apr 26
$9.70
0[0.00%]
After Hours: 7:14PM EDT
Precision BioSciences
(NASDAQ:DTIL)Precision BioSciences Stock (NASDAQ:DTIL), Analyst Ratings, Price Targets, Predictions
Precision BioSciences Inc has a consensus price target of $15.5, established from looking at the 18 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on April 17, 2024, March 28, 2024, and February 14, 2024. With an average price target of $41 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 322.68% upside for Precision BioSciences Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
BTIG
BMO Capital
Goldman Sachs
William Blair
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Precision BioSciences
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/17/2024 | DTIL | Buy Now | Precision BioSciences | $9.70 | 518.56% | HC Wainwright & Co. | Patrick Trucchio | → $60 | Reiterates | Buy → Buy | Get Alert |
| 03/28/2024 | DTIL | Buy Now | Precision BioSciences | $9.70 | 518.56% | HC Wainwright & Co. | Patrick Trucchio | $3 → $60 | Maintains | Buy | Get Alert |
| 02/14/2024 | DTIL | Buy Now | Precision BioSciences | $9.70 | -69.07% | HC Wainwright & Co. | Patrick Trucchio | → $3 | Reiterates | Buy → Buy | Get Alert |
| 09/19/2023 | DTIL | Buy Now | Precision BioSciences | $9.70 | -69.07% | HC Wainwright & Co. | Patrick Trucchio | → $90 | Reiterates | Buy → Buy | Get Alert |
| 08/17/2023 | DTIL | Buy Now | Precision BioSciences | $9.70 | -69.07% | HC Wainwright & Co. | Patrick Trucchio | $150 → $90 | Maintains | Buy | Get Alert |
| 08/07/2023 | DTIL | Buy Now | Precision BioSciences | $9.70 | — | HC Wainwright & Co. | Patrick Trucchio | — | Reiterates | → Buy | Get Alert |
| 07/28/2023 | DTIL | Buy Now | Precision BioSciences | $9.70 | -79.38% | BTIG | Thomas Shrader | $180 → $60 | Maintains | Buy | Get Alert |
| 07/28/2023 | DTIL | Buy Now | Precision BioSciences | $9.70 | -48.45% | HC Wainwright & Co. | Patrick Trucchio | $510 → $150 | Reiterates | Buy → Buy | Get Alert |
| 06/01/2023 | DTIL | Buy Now | Precision BioSciences | $9.70 | 75.26% | HC Wainwright & Co. | Patrick Trucchio | → $510 | Reiterates | Buy → Buy | Get Alert |
| 03/15/2023 | DTIL | Buy Now | Precision BioSciences | $9.70 | 75.26% | HC Wainwright & Co. | Patrick Trucchio | → $510 | Reiterates | → Buy | Get Alert |
| 03/14/2023 | DTIL | Buy Now | Precision BioSciences | $9.70 | -58.76% | BMO Capital | Kostas Biliouris | $210 → $120 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/10/2022 | DTIL | Buy Now | Precision BioSciences | $9.70 | -89.69% | Goldman Sachs | Salveen Richter | $60 → $30 | Maintains | Neutral | Get Alert |
| 11/10/2022 | DTIL | Buy Now | Precision BioSciences | $9.70 | 75.26% | HC Wainwright & Co. | Patrick Trucchio | $600 → $510 | Maintains | Buy | Get Alert |
| 08/09/2022 | DTIL | Buy Now | Precision BioSciences | $9.70 | -79.38% | Goldman Sachs | Salveen Richter | $90 → $60 | Maintains | Neutral | Get Alert |
| 06/17/2022 | DTIL | Buy Now | Precision BioSciences | $9.70 | -27.84% | BMO Capital | Kostas Biliouris | → $210 | Initiates | → Outperform | Get Alert |
| 06/09/2022 | DTIL | Buy Now | Precision BioSciences | $9.70 | — | William Blair | Raju Prasad | — | Downgrade | Outperform → Market Perform | Get Alert |
| 03/16/2022 | DTIL | Buy Now | Precision BioSciences | $9.70 | -48.45% | Goldman Sachs | Salveen Richter | $360 → $150 | Maintains | Neutral | Get Alert |
| 09/10/2021 | DTIL | Buy Now | Precision BioSciences | $9.70 | 168.04% | Stifel | Benjamin Burnett | $690 → $780 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Precision BioSciences (DTIL)?
The latest price target for Precision BioSciences (NASDAQ: DTIL) was reported by HC Wainwright & Co. on April 17, 2024. The analyst firm set a price target for $60.00 expecting DTIL to rise to within 12 months (a possible 518.56% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Precision BioSciences (DTIL)?
The latest analyst rating for Precision BioSciences (NASDAQ: DTIL) was provided by HC Wainwright & Co., and Precision BioSciences reiterated their buy rating.
When was the last upgrade for Precision BioSciences (DTIL)?
There is no last upgrade for Precision BioSciences.
When was the last downgrade for Precision BioSciences (DTIL)?
The last downgrade for Precision BioSciences Inc happened on March 14, 2023 when BMO Capital changed their price target from $7 to $4 for Precision BioSciences Inc.
When is the next analyst rating going to be posted or updated for Precision BioSciences (DTIL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Precision BioSciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Precision BioSciences was filed on April 17, 2024 so you should expect the next rating to be made available sometime around April 17, 2025.
Is the Analyst Rating Precision BioSciences (DTIL) correct?
While ratings are subjective and will change, the latest Precision BioSciences (DTIL) rating was a reiterated with a price target of $0.00 to $60.00. The current price Precision BioSciences (DTIL) is trading at is $9.70, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.